AE-05-GR23_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, Gnf-5, Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors targeting ABL1, BCR, ABL2 (Novartis, 44129660)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/44129660
Similar Terms
Downloads & Tools

Genes

15 genes differentially expressed following the AE-05-GR23_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
FBXW5 F-box and WD repeat domain containing 5 0.614793
WDR46 WD repeat domain 46 0.589743
HMGA1 high mobility group AT-hook 1 0.219846

decreased expression

Symbol Name Standardized Value
SRR serine racemase -0.388253
BUB1B BUB1 mitotic checkpoint serine/threonine kinase B -0.326152
RAN RAN, member RAS oncogene family -0.316481
RHOA ras homolog family member A -0.253165
AARD alanine and arginine rich domain containing protein -0.253165
PPM1D protein phosphatase, Mg2+/Mn2+ dependent, 1D -0.253165
RPS6KB1 ribosomal protein S6 kinase, 70kDa, polypeptide 1 -0.226799
TULP4 tubby like protein 4 -0.226799
TPM1 tropomyosin 1 (alpha) -0.20692
TPD52L1 tumor protein D52-like 1 -0.20692
ADRA1B adrenoceptor alpha 1B -0.200216
PDCD6IP programmed cell death 6 interacting protein -0.200216